DELFI Diagnostics, Inc., developer of accessible blood-based liquid biopsy tests that deliver a new way to enhance early cancer detection, is announcing the appointment...
Indigenous Pact, a leader in creating health equity for American Indians and Alaska Natives (AI/AN), and DELFI Diagnostics, Inc., a developer of accessible blood-based tests...
Agena Bioscience and nRichDX have advanced their existing technical collaboration to a commercial partnership that co-promotes their products to researchers developing liquid biopsy applications...
Delfi Diagnostics, a pioneering developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection and monitoring, has been selected...
Viome Life Sciences, a mission-driven biotechnology company, announces the arrival of its CancerDetect test for oral & throat cancer, the first to launch in...
